TMO
Thermo Fisher Scientific IncHealthcare$491.46
▼ Bearish
Mkt Cap: $182.57B|Float: 370.6M|SI: 1.0%|DTC: 1.8
Data as of market close Apr 2, 2026
IV Rank
31
IV Pctl
33%
HV 20d
30.6%
52W Range
$384-$643
ATR(14)
$14.08
Exp. Move
±2.1%
P/C Ratio
1.33
Earnings
Apr 22
GEX Negative
DEX Long
Net Put Premium
IV Moderate
Max Pain Below
Exp. Move Moderate
High Put/Call
TMO Key Options Data
- IV Rank
- 31.1%
- Total GEX
- $-0.00B
- Total DEX
- $1.3M
- Max Pain
- $480.00
- Expected Move
- ±2.1%
- Put/Call OI
- 1.33
- Net Premium
- $-3.5M
- Spot Price
- $491.46
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-10 | 8 | ±$10.20 | ±2.1% | $481.26 | $501.66 |
| 2026-04-17 | 15 | ±$26.30 | ±5.3% | $465.16 | $517.76 |
| 2026-04-24 | 22 | ±$40.55 | ±8.3% | $450.91 | $532.01 |
| 2026-05-01 | 29 | ±$22.25 | ±4.5% | $469.21 | $513.71 |
| 2026-05-15 | 43 | ±$49.05 | ±10.0% | $442.41 | $540.51 |
| 2026-06-18 | 77 | ±$62.25 | ±12.7% | $429.21 | $553.71 |
Explore TMO options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.